Condition: Bone Marrow Edema · Knee Pain Chronic · Knee Osteoarthritis · Sponsor: Zimmer Biomet
This is a multi-center, prospective, single-blinded, two-arm study, randomized to include approximately 134 subjects treated with Subchondroplasty (SCP) + Arthroscopy and 67 subjects with arthroscopy alone. The primary objective of this study is to demonstrate superiority of Subchondroplasty with arthroscopy compared to arthroscopy alone for treatment of Bone Marrow Lesions (BMLs) in the knee.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| CORE Orthopaedic Medical Center | Encinitas, California, United States | — |
| Loma Linda University Health System | Loma Linda, California, United States | — |
| Stanford University | Stanford, California, United States | — |
| Foundation for Orthopaedic Research and Education | Tampa, Florida, United States | — |
| Emory University | Atlanta, Georgia, United States | — |
| Rush University Medical Center | Chicago, Illinois, United States | — |
| MedStar Health Research Institute | Timonium, Maryland, United States | — |
| New Mexico Orthopaedic Fellowship Foundation | Albuquerque, New Mexico, United States | — |
| The Ohio State University | Columbus, Ohio, United States | — |
| Hawkins Foundation | Greenville, South Carolina, United States | — |
| Orthopedic Associates of Central Texas | Austin, Texas, United States | — |
| University of Virginia | Charlottesville, Virginia, United States | — |
+ 1 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.